Science Translational Medicine

Basic Information

Brief Name: SCI TRANSL MED
Impact Factor: 15.8
ISSN: 1946-6234
Research Field: MEDICAL
h-index: 168
Self-citation Rate: 0.6%
Articles per Year: 271

SCI Index Status: Science Citation Index Expanded
Journal Website: https://www.science.org/journal/stm
Journal Introduction:

Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine. Despite 50 years of progress in our fundamental understanding of human biology and the emergence of powerful new technologies, the translation of this knowledge into effective new treatments and health measures has been slow. Science Translational Medicine seeks to publish articles that fill the scientific knowledge gaps at the junction of preclinical research and medical applications in order to accelerate the translation of this knowledge into new ways for preventing, diagnosing and treating human disease. Scope Cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine. Examples of content in Science Translational Medicine: Investigative studies of human biology with an emphasis on disease, including small clinical trials Research on models of human disease with significant implications for disease treatment Focus, Perspectives and Reviews that discuss medically related research from a basic science and a clinical point of view Commentary on policy, funding, education and regulatory issues in translational medicine Survey of recent noteworthy findings from other publications (Editor's Choice) Special issues that feature comprehensive reviews and analyses of current topics in translational medicine

CiteScore

CiteScore
26.7
SJR
6.51
SNIP
2.59
Subject Rank Percentile
MedicineGeneral Medicine
11 / 636 98%

Journal Statistics

Weekly
Issues/Year
Submission to 1st Decision: 7 days Submission to 1st Post-Review Decision: 63 days Submission to Acceptance: 190.5 days Accept to Publish: 23 days
Review Cycle
Article Processing Fee

Submission Information

Submission Website:

https://cts.sciencemag.org/scc/login.html

Accepted Types:

Research Articles
Research Resources
Technical Comments
Reviews
Editorials
Focus
Perspectives

Related Articles

Courses

Other

DOI: 10.1039/AN995200026N

British Standards Institution

Other

DOI: 10.1039/AN938630664A

Ministry of Supply. Triple superphosphate

Other

DOI: 10.1039/AN942670101A

Ministry of Health. Keeping quality of milk

Other

DOI: 10.1039/AN942670292A

Contents pages

Other

DOI: 10.1039/AN94267BX031

Ministry of Food.—statutory rules and orders

Other

DOI: 10.1039/AN942670261B

Erratum

Other

DOI: 10.1039/AN938630896A

Food and drugs

Other

DOI: 10.1039/AN938630604B

You might also like

Compound Q&A

What is Ethyl 3-cyclohexylpropanoate (CAS: 10094-36-7)?

Ethyl 3-cyclohexylpropanoate is a clear, colorless to light yellow liquid with a...

10094-36-7Ethyl 3-cyclohexylpr...
Compound Q&A

How should waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)nicotinic acid (CAS: 34783-31-8) be handled?

Waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl...

34783-31-82-(Hydroxymethyl)-5-...
Compound Q&A

How should waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) be handled?

Waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) sho...

858-46-82,4,6-Tris(pentafluo...
Compound Q&A

What precautions should be taken when handling Chloroac-nle-oh (CAS: 56787-36-1)?

When handling Chloroac-nle-oh (CAS: 56787-36-1), it is essential to wear appropr...

56787-36-1Chloroac-nle-oh
Compound Q&A

What industries use Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate (CAS: 752244-05-6)?

Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate is primarily used in the...

752244-05-6Ethyl 6-phenylimidaz...
Compound Q&A

Are there alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis?

Alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis ...

55095-15-3alpha-(2-Bromophenyl...
Compound Q&A

How should waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) be handled?

Waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) should be managed...

139585-48-12-Chloro-5-methoxypy...
Compound Q&A

What industries use 1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9)?

1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9) is used in various ...

5044-27-91-(4-Methoxyphenyl)-...
Compound Q&A

Are there alternatives to 3-Bromo-5-(N-Boc)aminomethylisoxazole (CAS: 903131-45-3) in synthesis?

There are alternative reagents and compounds that can be used in the synthesis o...

903131-45-33-Bromo-5-(N-Boc)ami...
Compound Q&A

What is Tungsten(IV) oxide (CAS: 12036-22-5)?

Tungsten(IV) oxide, also known as tungsten dioxide, is a chemical compound with ...

12036-22-5Tungsten(IV) oxide
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.